SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Singer who wrote (1906)6/10/1997 12:06:00 AM
From: Tunica Albuginea   of 3991
 
Ricc.,I believe Dr.Nathan's credibility at this point is withering
fairly rapidly if what he was quoted correctly by Barron's in the article:
you cannot go in the NEJM and saythat you studied 1500 people and Muse
works 40 -60 % , and then go into Barron's, and without having his medical
opinion challenged go and say that it only works in 5 % of patients
and only the tip gets hard; where is Barron's opinion of the other 50
urologists who contributed to the paper? When Barron's saw a 180 o
turn of opinion by this doctor don't you think it had a duty to check
it out with the other 50 docs? I don't know anything about this conference
inNew York.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext